{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:20:19Z","timestamp":1765545619111,"version":"3.37.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00213-010-1863-2","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T04:39:59Z","timestamp":1272602399000},"page":"591-604","source":"Crossref","is-referenced-by-count":20,"title":["Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists"],"prefix":"10.1007","volume":"210","author":[{"given":"Aude","family":"Burban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chit","family":"Sadakhom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwena\u00eblle","family":"Le Pen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette","family":"Frances","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Arrang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"key":"1863_CR1","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/npp.2008.41","volume":"33","author":"S Arai","year":"2008","unstructured":"Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Takahashi K, Kamei H, Nabeshima T, Yamada K (2008) Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacology 33:3164\u20133175","journal-title":"Neuropsychopharmacology"},{"key":"1863_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0074-7742(06)78009-6","volume":"78","author":"JM Arrang","year":"2007","unstructured":"Arrang JM (2007) Histamine and schizophrenia. Int Rev Neurobiol 78:247\u2013287","journal-title":"Int Rev Neurobiol"},{"key":"1863_CR3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"JM Arrang","year":"1983","unstructured":"Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832\u2013837","journal-title":"Nature"},{"key":"1863_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/327117a0","volume":"327","author":"JM Arrang","year":"1987","unstructured":"Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC (1987) Highly potent and selective ligands for histamine H3-receptors. Nature 327:117\u2013123","journal-title":"Nature"},{"key":"1863_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.1988.tb04841.x","volume":"51","author":"JM Arrang","year":"1988","unstructured":"Arrang JM, Devaux B, Chodkiewicz JP, Schwartz JC (1988) H3-receptors control histamine release in human brain. J Neurochem 51:105\u2013108","journal-title":"J Neurochem"},{"key":"1863_CR6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tips.2007.05.002","volume":"28","author":"JM Arrang","year":"2007","unstructured":"Arrang JM, Morisset S, Gbahou F (2007) Constitutive activity of the histamine H3 receptor. Trends Pharmacol Sci 28:350\u2013357","journal-title":"Trends Pharmacol Sci"},{"key":"1863_CR7","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/sj.npp.1301015","volume":"31","author":"AL Auclair","year":"2006","unstructured":"Auclair AL, Kleven MS, Besnard J, Depoortere R, Newman-Tancredi A (2006) Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade. Neuropsychopharmacology 31:1900\u20131909","journal-title":"Neuropsychopharmacology"},{"key":"1863_CR8","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1523\/JNEUROSCI.18-20-08394.1998","volume":"18","author":"VP Bakshi","year":"1998","unstructured":"Bakshi VP, Geyer MA (1998) Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18:8394\u20138401","journal-title":"J Neurosci"},{"key":"1863_CR9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(00)00409-3","volume":"67","author":"T Bast","year":"2000","unstructured":"Bast T, Zhang W, Feldon J, White IM (2000) Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats. Pharmacol Biochem Behav 67:647\u2013658","journal-title":"Pharmacol Biochem Behav"},{"key":"1863_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00213-003-1589-5","volume":"171","author":"M Bortolato","year":"2004","unstructured":"Bortolato M, Frau R, Aru GN, Orru M, Gessa GL (2004) Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine. Psychopharmacology (Berl) 171:322\u2013330","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR11","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","volume":"33","author":"M Bortolato","year":"2008","unstructured":"Bortolato M, Frau R, Orru M, Bourov Y, Marrosu F, Mereu G, Devoto P, Gessa GL (2008) Antipsychotic-like properties of 5-alpha-reductase inhibitors. Neuropsychopharmacology 33:3146\u20133156","journal-title":"Neuropsychopharmacology"},{"key":"1863_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234\u2013258","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.2007.164.5.705","volume":"164","author":"D Braff","year":"2007","unstructured":"Braff D, Schork NJ, Gottesman II (2007) Endophenotyping schizophrenia. Am J Psychiatry 164:705\u2013707","journal-title":"Am J Psychiatry"},{"key":"1863_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00213-003-1635-3","volume":"172","author":"SA Brody","year":"2004","unstructured":"Brody SA, Conquet F, Geyer MA (2004) Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice. Psychopharmacology (Berl) 172:187\u2013195","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","volume":"153","author":"KE Browman","year":"2004","unstructured":"Browman KE, Komater VA, Curzon P, Rueter LE, Hancock AA, Decker MW, Fox GB (2004) Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153:69\u201376","journal-title":"Behav Brain Res"},{"key":"1863_CR16","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S1359-6446(05)03625-1","volume":"10","author":"S Celanire","year":"2005","unstructured":"Celanire S, Wijtmans M, Talaga P, Leurs R, de Esch IJ (2005) Histamine H3 receptor antagonists reach out for the clinic. Drug Discov Today 10:1613\u20131627","journal-title":"Drug Discov Today"},{"key":"1863_CR17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","volume":"259","author":"J Clapham","year":"1994","unstructured":"Clapham J, Kilpatrick GJ (1994) Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 259:107\u2013114","journal-title":"Eur J Pharmacol"},{"key":"1863_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0278-5846(97)00184-X","volume":"22","author":"P Curzon","year":"1998","unstructured":"Curzon P, Decker MW (1998) Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry 22:129\u2013146","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1863_CR19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1124\/jpet.107.135368","volume":"326","author":"E Davenas","year":"2008","unstructured":"Davenas E, Rouleau A, Morisset S, Arrang JM (2008) Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors. J Pharmacol Exp Ther 326:406\u2013413","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR20","first-page":"139","volume":"39","author":"SC Dulawa","year":"1996","unstructured":"Dulawa SC, Geyer MA (1996) Psychopharmacology of prepulse inhibition in mice. Chin J Physiol 39:139\u2013146","journal-title":"Chin J Physiol"},{"key":"1863_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevNeurobiol.v14.i1.10","volume":"14","author":"B Elvevag","year":"2000","unstructured":"Elvevag B, Goldberg TE (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14:1\u201321","journal-title":"Crit Rev Neurobiol"},{"key":"1863_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.104.078303","volume":"313","author":"TA Esbenshade","year":"2005","unstructured":"Esbenshade TA, Fox GB, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan L, Wetter J, Marsh K, Bennani YL, Cowart MD, Sullivan JP, Hancock AA (2005) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties. J Pharmacol Exp Ther 313:165\u2013175","journal-title":"J Pharmacol Exp Ther"},{"issue":"77\u201388","key":"1863_CR23","first-page":"59","volume":"6","author":"TA Esbenshade","year":"2006","unstructured":"Esbenshade TA, Fox GB, Cowart MD (2006) Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv 6(77\u201388):59","journal-title":"Mol Interv"},{"key":"1863_CR24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1471-4159.2006.04002.x","volume":"98","author":"R Faucard","year":"2006","unstructured":"Faucard R, Armand V, Heron A, Cochois V, Schwartz JC, Arrang JM (2006) N-Methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain. J Neurochem 98:1487\u20131496","journal-title":"J Neurochem"},{"key":"1863_CR25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130051103","volume":"146","author":"D Feifel","year":"1999","unstructured":"Feifel D, Priebe K (1999) The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating. Psychopharmacology (Berl) 146:175\u2013179","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","volume":"55","author":"C Ferrada","year":"2008","unstructured":"Ferrada C, Ferre S, Casado V, Cortes A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R (2008) Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55:190\u2013197","journal-title":"Neuropharmacology"},{"key":"1863_CR27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"GB Fox","year":"2005","unstructured":"Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313:176\u2013190","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR28","first-page":"689","volume-title":"Neuropsychopharmacology: the fifth generation of progress","author":"M Geyer","year":"2002","unstructured":"Geyer M, Moghaddam B (2002) Animal models relevant to schizophrenia disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins, Philadelphia, pp 689\u2013701"},{"key":"1863_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117\u2013154","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrn1034","volume":"4","author":"H Haas","year":"2003","unstructured":"Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4:121\u2013130","journal-title":"Nat Rev Neurosci"},{"key":"1863_CR31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","volume":"88","author":"HL Haas","year":"2008","unstructured":"Haas HL, Sergeeva OA, Selbach O (2008) Histamine in the nervous system. Physiol Rev 88:1183\u20131241","journal-title":"Physiol Rev"},{"key":"1863_CR32","first-page":"1190","volume":"4","author":"AA Hancock","year":"2003","unstructured":"Hancock AA (2003) H3 receptor antagonists\/inverse agonists as anti-obesity agents. Curr Opin Investig Drugs 4:1190\u20131197","journal-title":"Curr Opin Investig Drugs"},{"key":"1863_CR33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1517\/13543784.13.10.1237","volume":"13","author":"AA Hancock","year":"2004","unstructured":"Hancock AA, Fox GB (2004) Perspectives on cognitive domains, H3 receptor ligands and neurological disease. Expert Opin Investig Drugs 13:1237\u20131248","journal-title":"Expert Opin Investig Drugs"},{"key":"1863_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","volume":"49","author":"SJ Hill","year":"1997","unstructured":"Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL (1997) International union of pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253\u2013278","journal-title":"Pharmacol Rev"},{"key":"1863_CR35","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bcp.2007.01.006","volume":"73","author":"M Humbert-Claude","year":"2007","unstructured":"Humbert-Claude M, Morisset S, Gbahou F, Arrang JM (2007) Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions. Biochem Pharmacol 73:1172\u20131181","journal-title":"Biochem Pharmacol"},{"key":"1863_CR36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0306-4522(02)00069-6","volume":"112","author":"N Hussain","year":"2002","unstructured":"Hussain N, Flumerfelt BA, Rajakumar N (2002) Muscarinic, adenosine A2 and histamine H3 receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens. Neuroscience 112:427\u2013438","journal-title":"Neuroscience"},{"key":"1863_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3565(25)20964-8","volume":"279","author":"C Ito","year":"1996","unstructured":"Ito C, Onodera K, Sakurai E, Sato M, Watanabe T (1996) Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J Pharmacol Exp Ther 279:271\u2013276","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0166-4328(01)00218-2","volume":"124","author":"C Kamei","year":"2001","unstructured":"Kamei C (2001) Involvement of central histamine in amygdaloid kindled seizures in rats. Behav Brain Res 124:243\u2013250","journal-title":"Behav Brain Res"},{"key":"1863_CR39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","volume":"7","author":"S Kapur","year":"2002","unstructured":"Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7:837\u2013844","journal-title":"Mol Psychiatry"},{"key":"1863_CR40","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","volume":"104","author":"L Kargieman","year":"2007","unstructured":"Kargieman L, Santana N, Mengod G, Celada P, Artigas F (2007) Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proc Natl Acad Sci USA 104:14843\u201314848","journal-title":"Proc Natl Acad Sci USA"},{"key":"1863_CR41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0006-3223(91)90025-H","volume":"30","author":"VA Keith","year":"1991","unstructured":"Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30:557\u2013566","journal-title":"Biol Psychiatry"},{"key":"1863_CR42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2009.02.003","volume":"32","author":"C Kellendonk","year":"2009","unstructured":"Kellendonk C, Simpson EH, Kandel ER (2009) Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci 32:347\u2013358","journal-title":"Trends Neurosci"},{"key":"1863_CR43","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1523\/JNEUROSCI.19-13-05644.1999","volume":"19","author":"GG Kinney","year":"1999","unstructured":"Kinney GG, Wilkinson LO, Saywell KL, Tricklebank MD (1999) Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci 19:5644\u20135653","journal-title":"J Neurosci"},{"key":"1863_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1631","volume":"4","author":"R Leurs","year":"2005","unstructured":"Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4:107\u2013120","journal-title":"Nat Rev Drug Discov"},{"key":"1863_CR45","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/BF02245006","volume":"112","author":"JE Leysen","year":"1993","unstructured":"Leysen JE, Janssen PM, Schotte A, Luyten WH, Megens AA (1993) Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology (Berl) 112:S40\u2013S54","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(24)37840-1","volume":"287","author":"X Ligneau","year":"1998","unstructured":"Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J (1998) Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 287:658\u2013666","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bcp.2007.01.023","volume":"73","author":"X Ligneau","year":"2007","unstructured":"Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin JS, Burban A, Arrang JM, Schwartz JC (2007a) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73:1215\u20131224","journal-title":"Biochem Pharmacol"},{"key":"1863_CR48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","volume":"320","author":"X Ligneau","year":"2007","unstructured":"Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC (2007b) BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther 320:365\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/smrv.2000.0116","volume":"4","author":"JS Lin","year":"2000","unstructured":"Lin JS (2000) Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev 4:471\u2013503","journal-title":"Sleep Med Rev"},{"key":"1863_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","volume":"30","author":"JS Lin","year":"2008","unstructured":"Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (2008) An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin\u2212\/\u2212 mice and patients. Neurobiol Dis 30:74\u201383","journal-title":"Neurobiol Dis"},{"key":"1863_CR51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(01)00561-5","volume":"69","author":"RS Mansbach","year":"2001","unstructured":"Mansbach RS, Carver J, Zorn SH (2001) Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. Pharmacol Biochem Behav 69:535\u2013542","journal-title":"Pharmacol Biochem Behav"},{"key":"1863_CR52","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35048583","volume":"408","author":"S Morisset","year":"2000","unstructured":"Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM (2000) High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408:860\u2013864","journal-title":"Nature"},{"key":"1863_CR53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.300.2.621","volume":"300","author":"S Morisset","year":"2002","unstructured":"Morisset S, Pilon C, Tardivel-Lacombe J, Weinstein D, Rostene W, Betancur C, Sokoloff P, Schwartz JC, Arrang JM (2002) Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. J Pharmacol Exp Ther 300:621\u2013628","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.10.022","volume":"505","author":"T Okuda","year":"2004","unstructured":"Okuda T, Ito Y, Nakagawa N, Hishinuma T, Tsukamoto H, Iwabuchi K, Watanabe T, Kitaichi K, Goto J, Yanai K (2004) Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats. Eur J Pharmacol 505:135\u2013144","journal-title":"Eur J Pharmacol"},{"key":"1863_CR55","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bcp.2007.01.002","volume":"73","author":"R Parmentier","year":"2007","unstructured":"Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS (2007) The brain H3-receptor as a novel therapeutic target for vigilance and sleep\u2013wake disorders. Biochem Pharmacol 73:1157\u20131171","journal-title":"Biochem Pharmacol"},{"key":"1863_CR56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tips.2004.10.003","volume":"25","author":"MB Passani","year":"2004","unstructured":"Passani MB, Lin JS, Hancock A, Crochet S, Blandina P (2004) The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25:618\u2013625","journal-title":"Trends Pharmacol Sci"},{"key":"1863_CR57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050333","volume":"132","author":"R Paylor","year":"1997","unstructured":"Paylor R, Crawley JN (1997) Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 132:169\u2013180","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","volume":"114","author":"C Pillot","year":"2002","unstructured":"Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM (2002a) A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain. Neuroscience 114:173\u2013193","journal-title":"Neuroscience"},{"key":"1863_CR59","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","volume":"22","author":"C Pillot","year":"2002","unstructured":"Pillot C, Ortiz J, Heron A, Ridray S, Schwartz JC, Arrang JM (2002b) Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat. J Neurosci 22:7272\u20137280","journal-title":"J Neurosci"},{"key":"1863_CR60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1460-9568.2003.02422.x","volume":"17","author":"C Pillot","year":"2003","unstructured":"Pillot C, Heron A, Schwartz JC, Arrang JM (2003) Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum. Eur J Neurosci 17:307\u2013314","journal-title":"Eur J Neurosci"},{"key":"1863_CR61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-9964(94)00034-6","volume":"14","author":"GD Prell","year":"1995","unstructured":"Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14:93\u2013104","journal-title":"Schizophr Res"},{"key":"1863_CR62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1124\/jpet.104.074468","volume":"312","author":"RJ Ralph","year":"2005","unstructured":"Ralph RJ, Caine SB (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1\/SvJ, C57BL\/6J, and DBA\/2J mice. J Pharmacol Exp Ther 312:733\u2013741","journal-title":"J Pharmacol Exp Ther"},{"key":"1863_CR63","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.1523\/JNEUROSCI.22-21-09604.2002","volume":"22","author":"RJ Ralph-Williams","year":"2002","unstructured":"Ralph-Williams RJ, Lehmann-Masten V, Otero-Corchon V, Low MJ, Geyer MA (2002) Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J Neurosci 22:9604\u20139611","journal-title":"J Neurosci"},{"key":"1863_CR64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.npp.1300017","volume":"28","author":"RJ Ralph-Williams","year":"2003","unstructured":"Ralph-Williams RJ, Lehmann-Masten V, Geyer MA (2003) Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28:108\u2013118","journal-title":"Neuropsychopharmacology"},{"key":"1863_CR65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","volume":"68","author":"E Richelson","year":"2000","unstructured":"Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68:29\u201339","journal-title":"Life Sci"},{"key":"1863_CR66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0892-0362(94)90022-1","volume":"16","author":"RB Rothman","year":"1994","unstructured":"Rothman RB (1994) PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site. Neurotoxicol Teratol 16:343\u2013353","journal-title":"Neurotoxicol Teratol"},{"key":"1863_CR67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.1996.tb15441.x","volume":"118","author":"JH Ryu","year":"1996","unstructured":"Ryu JH, Yanai K, Zhao XL, Watanabe T (1996) The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones. Br J Pharmacol 118:585\u2013592","journal-title":"Br J Pharmacol"},{"key":"1863_CR68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00213-008-1310-9","volume":"201","author":"E Southam","year":"2009","unstructured":"Southam E, Cilia J, Gartlon JE, Woolley ML, Lacroix LP, Jennings CA, Cluderay JE, Reavill C, Rourke C, Wilson DM, Dawson LA, Medhurst AD, Jones DN (2009) Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. Psychopharmacology (Berl) 201:483\u2013494","journal-title":"Psychopharmacology (Berl)"},{"key":"1863_CR69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.62.2.389","volume":"62","author":"H Toyota","year":"2002","unstructured":"Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW (2002) Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol 62:389\u2013397","journal-title":"Mol Pharmacol"},{"key":"1863_CR70","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/FBP.0b013e32831c3b2b","volume":"19","author":"M Weber","year":"2008","unstructured":"Weber M, Chang WL, Breier M, Ko D, Swerdlow NR (2008) Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behav Pharmacol 19:786\u2013795","journal-title":"Behav Pharmacol"},{"key":"1863_CR71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2005.03.018","volume":"1045","author":"M Zhang","year":"2005","unstructured":"Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE (2005) Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug\u2013drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Brain Res 1045:142\u2013149","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-010-1863-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1863-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:06:45Z","timestamp":1740053205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-010-1863-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1007\/s00213-010-1863-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}